Skip directly to page options Skip directly to A-Z link
Volume 30, Supplement—October 2024
SUPPLEMENT ISSUE
Articles

Serosurveillance for Plasmodium falciparum Malaria in Peruvian Army Peacekeeping Personnel, Central African Republic, 2021–2022

Julio A. Ventocilla, Hugo O. Valdivia, Marianela Ore, Rocio Santos, Edson Maguina, Danielle L. Pannebaker, Aida M. Delgado-Flores, and Juan F. SanchezComments to Author 
Author affiliation: Vysnova Partners, Inc., Alexandria, Virginia, USA (J.A. Ventocilla, R. Santos, E. Maguina); US Naval Medical Research Unit SOUTH, Callao, Peru (H.O. Valdivia, D.L. Pannebaker, J.F. Sanchez); Comando Conjunto del Ejercito del Peru, Lima, Peru (M. Ore); Hospital Militar Central Luis Arias Schrieber, Lima (A.M. Delgado-Flores)

Main Article

Figure 2

Seroprevalence against Plasmodium falciparum malaria in Peruvian Army peacekeepers deployed to Central African Republic, July 2021–June 2022. Dot plot of OD492 of P. falciparum C-terminal 19-kDa region merozoite surface protein 1 by ELISA assay, with negative control group (black circles, n = 20) and Peruvian Army peacekeepers (blue squares, n = 97), 31 (31.9%) of whom were seropositive. Red line represents the cutoff determined by the average value plus 3 standard deviations of negative OD492 control values; black line represents the mean of OD492 values per group. OD492, optical density at 492 nm.

Figure 2. Seroprevalence against Plasmodium falciparum malaria in Peruvian Army peacekeepers deployed to Central African Republic, July 2021–June 2022. Dot plot of OD492 of P. falciparum C-terminal 19-kDa region merozoite surface protein 1 by ELISA assay, with negative control group (black circles, n = 20) and Peruvian Army peacekeepers (blue squares, n = 97), 31 (31.9%) of whom were seropositive. Red line represents the cutoff determined by the average value plus 3 standard deviations of negative OD492 control values; black line represents the mean of OD492 values per group. OD492, optical density at 492 nm.

Download

Main Article

Page created: September 05, 2024
Page updated: November 11, 2024
Page reviewed: November 11, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external